GlaxoSmithKline fires head of its China based research arm for misrepresentation of dataBMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f3914 (Published 14 June 2013) Cite this as: BMJ 2013;346:f3914
- Clare Dyer
British pharmaceutical giant GlaxoSmithKline (GSK) has fired the head of its China based research arm and is seeking the retraction of an article in Nature Medicine after a company investigation found evidence of misrepresentation.
GSK announced the dismissal of the paper’s coauthor, neurologist Jingwu Zhang, a senior vice president and head of R&D China in Shanghai. A second author has resigned and three others are on …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial